Toujeo Medicare Coverage

Toujeo is a prescription medication that contains the active ingredient insulin glargine, which is a long acting insulin.

Toujeo is provided as a pen injection device and can be injected on top of the thigh, the belly area or upper arm. This medication is injected once or multiple times daily, depending on your insulin regimen.

The major side effects of Toujeo include irritation where the shot is given, back pain, diarrhea, headache, weight gain and nose or throat irritation.

How much does Toujeo cost with Medicare?

Toujeo coverage and costs may vary based on the specific plan you have, as well as what coverage stage you're in.

Contact your plan carrier or consult your plan formulary for more cost information.

Does Medicare cover Toujeo?

According to GoodRx, 96% of Medicare Advantage plans and Medicare Part D plans covered Toujeo in 2023.¹

• Medicare Advantage plans or Part D plans that cover Toujeo include copay amounts that can range widely from one plan to another. Plan members may also be responsible for meeting a deductible before the plan’s drug coverage kicks in.
  
  
• Medicare Advantage plans that offer prescription drug coverage are called Medicare Advantage Prescription Drug Plans (MA-PD). 89% of 2024 Medicare Advantage plans include prescription drug coverage.²
  
  
• Medicare prescription drugs plans each have their own formulary, or drug list, that details what prescription drugs are covered by the plan and how they are covered.

Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Toujeo. We represent carriers such as Humana, UnitedHealthcare^®, Anthem Blue Cross and Blue Shield, Aetna, Cigna Healthcare, Wellcare, or Kaiser Permanente.

You can also compare Part D prescription drug plans available where you live and enroll in a Medicare prescription drug plan online when you visit MyRxPlans.com.

Additional information

Your Toujeo dose may be adjusted continuously to achieve glucose control and to avoid low blood sugar.

Low blood sugar can happen while taking Toujeo. Signs of low blood sugar include dizziness, headache, sleepiness, weakness, hunger, shaking, confusion and sweating. Talk to your doctor if you experience these symptoms.

Toujeo should be avoided in patients with diabetic ketoacidosis and used with caution for patients with liver and kidney impairment.

Your pen injection device should never be used for more than 1 person – even after the needle is changed – because of the risk of infection. The injection device should be clearly labeled with individual patient information to ensure that the correct pen is used.

Call your doctor if you experience signs of low potassium (e.g., weakness, muscle pain, muscle cramps, unusual heartbeat), signs of infection, dizziness or passing out, seizures, shortness of breath, weight gain, swelling of the arms and legs or change in mood.

This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.

Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.

Written by Hayden Gharibyar, Pharm.D.